Preliminary study: Treatment with intramuscular interferon beta-1a results in increased levels of IL-12Rβ2<sup>+ </sup>and decreased levels of IL23R<sup>+ </sup>CD4<sup>+ </sup>T - Lymphocytes in multiple sclerosis
<p>Abstract</p> <p>Background</p> <p>There are a lack of biomarkers which can be used to predict clinical outcomes for multiple sclerosis (MS) patients receiving interferon beta (IFN-β). Thus the objective of this study was to characterize changes in CD4+ T-lymphocyte e...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-12-01
|
| Series: | BMC Neurology |
| Online Access: | http://www.biomedcentral.com/1471-2377/11/155 |